Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 23 May 2019
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 23 Jul 2018 Status changed from active, no longer recruiting to completed.
- 05 Apr 2018 Status changed from recruiting to active, no longer recruiting.